These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38541685)

  • 21. An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists.
    Sardana K; Muddebihal A; Sehrawat M; Bansal P; Khurana A
    Expert Rev Endocrinol Metab; 2024 Mar; 19(2):111-128. PubMed ID: 38205927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
    Rosenfield RL; Lucky AW
    Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors.
    Sanchón R; Gambineri A; Alpañés M; Martínez-García MÁ; Pasquali R; Escobar-Morreale HF
    Hum Reprod; 2012 Apr; 27(4):1209-16. PubMed ID: 22343706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
    Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
    BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperandrogenism caused by a rare adrenocortical oncocytic neoplasm with uncertain malignant potential: a case report and review of the literature.
    Bao Z; He W; Di W; Gao H
    Endocr J; 2023 Mar; 70(3):275-280. PubMed ID: 36384706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
    Rachoń D
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):205-9. PubMed ID: 22421986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-PCOS Hyperandrogenic Disorders in Adolescents.
    Esquivel-Zuniga MR; Kirschner CK; McCartney CR; Burt Solorzano CM
    Semin Reprod Med; 2022 Mar; 40(1-02):42-52. PubMed ID: 35052005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.
    Bahtiyar G; Weiss K; Sacerdote AS
    Endocr Pract; 2007 Oct; 13(6):601-8. PubMed ID: 17954415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
    Abraham GE; Maroulis GB; Buster JE; Chang RJ; Marshall JR
    Obstet Gynecol; 1976 Apr; 47(4):395-402. PubMed ID: 130572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J; Chanukvadze D
    Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for investigation of hyperandrogenism.
    Pugeat M; Déchaud H; Raverot V; Denuzière A; Cohen R; Boudou P;
    Ann Endocrinol (Paris); 2010 Feb; 71(1):2-7. PubMed ID: 20096825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian and adrenal hyperandrogenism.
    Carmina E
    Ann N Y Acad Sci; 2006 Dec; 1092():130-7. PubMed ID: 17308139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders.
    Yilmaz B; Yildiz BO
    Front Horm Res; 2019; 53():108-119. PubMed ID: 31499500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M
    J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic evaluation of hirsutism in women.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperandrogenism and Its Possible Effects on Endometrial Receptivity: A Review.
    Yusuf ANM; Amri MF; Ugusman A; Hamid AA; Wahab NA; Mokhtar MH
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.